SenzaGen
Pre-clinicalIn Vitro Skin Sensitization Testing, GARDskin OECD 442E, Biocompatibility ISO 10993-10, Regulatory Toxicity Testing, GLP-Compliant Laboratory
Founded
2007
Focus
Genetics & Genomics
About
In Vitro Skin Sensitization Testing, GARDskin OECD 442E, Biocompatibility ISO 10993-10, Regulatory Toxicity Testing, GLP-Compliant Laboratory
Funding History
3Total raised: $14.5M
Series B$8MFårnholm InvestJun 15, 2020
Series A$5MFårnholm InvestOct 15, 2017
Seed$1.5MUndisclosedJun 15, 2015
Company Info
TypePrivate
Founded2007
LocationLund, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile